PHARMES
InactiveHistory
Acts, filings and financial milestones
2024
23-09
Gazette deed
End & cessationAppointment: Boes Joseph-Michel Bedrijfsrevisor BV (statutory auditor) · Net-asset statement · Auditor report18 facts ▸
Gazette deed
End & cessation
Appointment: Boes Joseph-Michel Bedrijfsrevisor BV (statutory auditor) · Net-asset statement · Auditor report18 facts ▸
- General meeting, 12-08-2024
- Other provision, 10-07-2024
- Auditor appointment, Boes Joseph-Michel Bedrijfsrevisor BV
- Net-asset statement, 30-06-2024
- Auditor report, 16-07-2024
- Dissolution, 12-08-2024
- Other provision, “staat van activa en passiva, geen passiva” (deed in Dutch)
- Other provision, “aandeelhouders, borgstelling onbekende passiva” (deed in Dutch)
- Other provision, “voor schuldeisers of aandeelhouders niet afgedragen bedragen, consignatie gelden en waarborgen” (deed in Dutch)
- Other provision, “benoeming vereffenaar” (deed in Dutch)
- Liquidation distribution, “terugname door aandeelhouders zelf, alle activa na sluiting nog blijkend,al dan niet bekend” (deed in Dutch) (2 times)
- Power of attorney, MARTENS Sven (vertegenwoordiger van één der aandeelhouders van alsdan vereffende vennootschap)
- +6 further facts in this act
19-06
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
2023
24-01
Gazette deed
Resignation: Cophar BV (director)Appointment: Essenzie BV (director) · Permanent representative: Inge Janssens · Registered-office move6 facts ▸
Gazette deed
Resignation: Cophar BV (director)
Appointment: Essenzie BV (director) · Permanent representative: Inge Janssens · Registered-office move6 facts ▸
- General meeting, 06-01-2023
- Director resignation, Cophar BV (director)
- Director appointment, Essenzie BV (director)
- Permanent representative, Inge Janssens
- Board meeting, 06-01-2023
- Registered-office move, Narcissenlaan 6 te 3550 HHeusden-Zolder
Gazette deedNBB filing
2 of 3 deeds read
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 2 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.